STAGE IV LUNG CANCER AJCC V8

This early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors or slo…

This study tested several targeted drugs (ALK inhibitors) and chemotherapy in people with a specific type of advanced lung cancer called ALK-positive non-squamous non-small cell lung cancer. The goal was to see which treatment worked best based on the patient's tumor markers. Onl…

This early-stage trial tested whether combining two immunotherapy drugs (atezolizumab and varlilumab) with radiation could help people whose advanced lung cancer had stopped responding to standard immunotherapy. Only 16 patients were enrolled before the study was ended early. The…

This study tested two drugs, bintrafusp alfa and pimasertib, in people whose cancer had spread to the brain. The goal was to find the best dose and see if the combination could slow or stop tumor growth. The trial was stopped early after enrolling only 8 participants, so no clear…

This study tested whether adding the immunotherapy drug bintrafusp alfa to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer whose disease worsened after prior treatment with immunotherapy and chemotherapy. The trial planned to enroll 10 adul…

This early-stage trial tested a new immunotherapy drug (BMS-986218) combined with another immunotherapy (nivolumab) and precise radiation for people with advanced solid tumors that had spread. The goal was to see if the combination was safe and could shrink tumors. The study was …

This study tested a mobile app that helps people with brain metastases from breast or lung cancer follow a time-restricted eating plan. The goal was to see if changing when they eat could reduce memory and thinking problems after radiation therapy. Only one person enrolled before…